Related Experiment Video
Updated: Jun 5, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
[New breakthroughs in Oncodermatology]
1Clinique de Dermatologie, CHRU Lille, rue Michel Polonovski, 59037 Lille, France. laurent.mortier@chru-lille.fr
Abstract:
During this year 2010, Oncodermatology was again the object of numerous publications. From the analysis of articles published between October 2009 and October 2010, choices had to be made. Overall, update on skin cancer has been dominated this year by breakthroughs on melanoma, which blows a wind of hope raised by the results of several clinical trials. Among those, it could be shown for the first time that a molecule was able to increase the overall survival of our patients (Ipilimumab). Spectacular results have also been obtained using anti-RAF. It seems that 2010 could be considered as a turning point in the therapeutic management of this cancer. In the field of lymphomas, several systemic treatments showed encouraging results in phase II and phase III trials.
Insights
2010 marked a turning point in cancer treatment, especially for melanoma. New therapies like Ipilimumab and anti-RAF treatments demonstrated significant survival benefits, offering new hope for patients.
Area of Science:
- Oncodermatology
- Dermatology
- Oncology
Background:
- Oncodermatology research saw numerous publications in 2010.
- The focus was on advancements in skin cancer and lymphoma treatments.
Purpose of the Study:
- To review and highlight key advancements in oncodermatology from October 2009 to October 2010.
- To identify breakthroughs in melanoma and lymphoma treatment.
Main Methods:
- Analysis of scientific articles published within a specific one-year period.
- Focus on clinical trial results and therapeutic management strategies.
Main Results:
- Melanoma treatment saw significant breakthroughs, including the first molecule (Ipilimumab) to improve overall survival.
- Anti-RAF therapies also yielded spectacular results in melanoma treatment.
- Encouraging results were reported for systemic treatments in lymphoma trials.
Conclusions:
- 2010 represents a potential turning point in the therapeutic management of melanoma.
- New systemic treatments show promise for lymphoma patients.
- Advancements in oncodermatology offer renewed hope for improved patient outcomes.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Renewal of Skin Epidermal Stem Cells
Confocal Fluorescence Microscopy
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

